Skip to main content
Top
Published in: Virology Journal 1/2007

Open Access 01-12-2007 | Research

Genetic characterisation of the recent foot-and-mouth disease virus subtype A/IRN/2005

Authors: Joern Klein, Manzoor Hussain, Munir Ahmad, Preben Normann, Muhammad Afzal, Soren Alexandersen

Published in: Virology Journal | Issue 1/2007

Login to get access

Abstract

Background

According to the World Reference Laboratory for FMD, a new subtype of FMDV serotype A was detected in Iran in 2005. This subtype was designated A/IRN/2005, and rapidly spread throughout Iran and moved westwards into Saudi Arabia and Turkey where it was initially detected from August 2005 and subsequently caused major disease problems in the spring of 2006. The same subtype reached Jordan in 2007. As part of an ongoing project we have also detected this subtype in Pakistan with the first positive samples detected in April 2006.
To characterise this subtype in detail, we have sequenced and analysed the complete coding sequence of three subtype A/IRN/2005 isolates collected in Pakistan in 2006, the complete coding sequence of one subtype A/IRN/2005 isolate collected during the first outbreak in Turkey in 2005 and, in addition, the partial 1D coding sequence derived from 4 epithelium samples and 34 swab-samples from Asian buffaloes or cattle subsequently found to be infected with the A/IRN/2005 subtype.

Results

The phylogenies of the genome regions encoding for the structural proteins, displayed, with the exception of 1A, distinct, serotype-specific clustering and an evolutionary relationship of the A/IRN/2005 sublineage with the A22 sublineage. Potential recombination events have been detected in parts of the genome region coding for the non-structural proteins of FMDV.
In addition, amino acid substitutions have been detected in the deduced VP1 protein sequence, potentially related to clinical or subclinical outcome of FMD.
Indications of differential susceptibility for developing a subclinical course of disease between Asian buffaloes and cattle have been detected.
Furthermore, hitherto unknown insertions of 2 amino acids before the second start codon, as well as sublineage specific amino acids have been detected in the genome region encoding for the leader proteinase of A/IRN/2005 sublineage.

Conclusion

Our findings indicate that the A/IRN/2005 sublineage has undergone two different paths of evolution for the structural and non-structural genome regions.
The structural genome regions have had their evolutionary starting point in the A22 sublineage. It can be assumed that, due to the quasispecies structure of FMDV populations and the error-prone replication process, advantageous mutations in a changed environment have been fixed and lead to the occurrence of the new A/IRN/2005 sublineage.
Together with this mechanism, recombination within the non-structural genome regions, potentially modifying the virulence of the virus, may be involved in the success of this new sublineage.
The possible origin of this recombinant virus may be a co-infection with Asia1 and a serotype A precursor of the A/IRN/2005 sublineage potentially within Asian Buffaloes, as these appears to relatively easy become infected, but usually without developing clinical disease and consequently showing not a strong acute inflammatory immune response against a second FMDV infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Alexandersen S, Mowat N: Foot-and-mouth disease: Host range and pathogenesis. Curr Top Microbiol Immunol 2005, 288: 9-42.PubMed Alexandersen S, Mowat N: Foot-and-mouth disease: Host range and pathogenesis. Curr Top Microbiol Immunol 2005, 288: 9-42.PubMed
2.
go back to reference Domingo E, Pariente N, Airaksinen A, Gonzalez-Lopez C, Sierra S, Herrera M, Grande-Perez A, Lowenstein PR, Manrubia SC, Lazaro E, Escarmis C: Foot-and-mouth disease virus evolution: Exploring pathways towards virus extinction. Curr Top Microbiol Immunol 2005, 288: 149-173.PubMed Domingo E, Pariente N, Airaksinen A, Gonzalez-Lopez C, Sierra S, Herrera M, Grande-Perez A, Lowenstein PR, Manrubia SC, Lazaro E, Escarmis C: Foot-and-mouth disease virus evolution: Exploring pathways towards virus extinction. Curr Top Microbiol Immunol 2005, 288: 149-173.PubMed
3.
go back to reference Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL: Comparative genomics of foot-and-mouth disease virus. J Virol 2005, 79: 6487-6504. 10.1128/JVI.79.10.6487-6504.2005PubMedPubMedCentralCrossRef Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL: Comparative genomics of foot-and-mouth disease virus. J Virol 2005, 79: 6487-6504. 10.1128/JVI.79.10.6487-6504.2005PubMedPubMedCentralCrossRef
4.
go back to reference Jackson AL, O'Neill H, Maree F, Blignaut B, Carrillo C, Rodriguez L, Haydon DT: Mosaic structure of foot-and-mouth disease virus genomes. J Gen Virol 2007, 88: 487-492. 10.1099/vir.0.82555-0PubMedCrossRef Jackson AL, O'Neill H, Maree F, Blignaut B, Carrillo C, Rodriguez L, Haydon DT: Mosaic structure of foot-and-mouth disease virus genomes. J Gen Virol 2007, 88: 487-492. 10.1099/vir.0.82555-0PubMedCrossRef
5.
go back to reference Kitching RP: Global epidemiology and prospects for control of foot-and-mouth disease. Curr Top Microbiol Immunol 2005, 288: 133-148.PubMed Kitching RP: Global epidemiology and prospects for control of foot-and-mouth disease. Curr Top Microbiol Immunol 2005, 288: 133-148.PubMed
6.
go back to reference PRO/AH > foot & mouth disease (type A) (03) – Jordan, Middle East. archive number 20070129.0380 PRO/AH > foot & mouth disease (type A) (03) – Jordan, Middle East. archive number 20070129.0380
7.
go back to reference Alexandersen S, Klein J, Hussain M, Paton D, Afzal M: Preliminary findings from a new project on the epidemiology of FMDV in Pakistan. Open Session of the Research Group of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD). International Control of Foot-and-Mouth Disease: Tools, trends and perspectives in Cyprus, 16–20 October 2006 Alexandersen S, Klein J, Hussain M, Paton D, Afzal M: Preliminary findings from a new project on the epidemiology of FMDV in Pakistan. Open Session of the Research Group of the European Commission for the Control of Foot-and-Mouth Disease (EUFMD). International Control of Foot-and-Mouth Disease: Tools, trends and perspectives in Cyprus, 16–20 October 2006
8.
go back to reference European Commission for the Control of Foot-and-Mouth Disease (EUFMD): RECOMMENDATIONS of the 73rd session of the executive committee european commission for the control of foot-and-mouth disease (EUFMD). Istanbul, Turkey. 2006. European Commission for the Control of Foot-and-Mouth Disease (EUFMD): RECOMMENDATIONS of the 73rd session of the executive committee european commission for the control of foot-and-mouth disease (EUFMD). Istanbul, Turkey. 2006.
9.
go back to reference Paton D: Report of the annual meeting of EU national foot-and-mouth disease laboratories. Brussels 22nd – 23rd November; 2006 Paton D: Report of the annual meeting of EU national foot-and-mouth disease laboratories. Brussels 22nd – 23rd November; 2006
10.
go back to reference Li D, Shang YJ, Liu ZX, Liu XT, Cai XP: Molecular relationships between type Asia 1 new strain from china and type O Panasia strains of foot-and-mouth-disease virus. Virus Genes 2007, 35: 273-279. 10.1007/s11262-006-0073-9PubMedCrossRef Li D, Shang YJ, Liu ZX, Liu XT, Cai XP: Molecular relationships between type Asia 1 new strain from china and type O Panasia strains of foot-and-mouth-disease virus. Virus Genes 2007, 35: 273-279. 10.1007/s11262-006-0073-9PubMedCrossRef
11.
go back to reference Klein J, Parlak U, Ozyoruk F, Christensen LS: The molecular epidemiology of foot-and-mouth disease virus serotypes A and O from 1998 to 2004 in Turkey. BMC Vet Res 2006, 2: 35. 10.1186/1746-6148-2-35PubMedPubMedCentralCrossRef Klein J, Parlak U, Ozyoruk F, Christensen LS: The molecular epidemiology of foot-and-mouth disease virus serotypes A and O from 1998 to 2004 in Turkey. BMC Vet Res 2006, 2: 35. 10.1186/1746-6148-2-35PubMedPubMedCentralCrossRef
12.
go back to reference Jackson T, Ellard FM, Ghazaleh RA, Brookes SM, Blakemore WE, Corteyn AH, Stuart DI, Newman JW, King AM: Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol 1996, 70: 5282-5287.PubMedPubMedCentral Jackson T, Ellard FM, Ghazaleh RA, Brookes SM, Blakemore WE, Corteyn AH, Stuart DI, Newman JW, King AM: Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol 1996, 70: 5282-5287.PubMedPubMedCentral
13.
go back to reference Sanyal A, Mohapatra JK, Kumar RM, Biswas S, Hemadri D, Tosh C, Sabarinath GP, Gupta SK, Mittal M, Giridharan P, Bandyopadhyay SK: Complete nucleotide sequence analysis of a vaccine strain and a field isolate of foot-and-mouth disease virus serotype Asia1 with an insertion in VP1 genomic region. Acta Virol 2004, 48: 159-166.PubMed Sanyal A, Mohapatra JK, Kumar RM, Biswas S, Hemadri D, Tosh C, Sabarinath GP, Gupta SK, Mittal M, Giridharan P, Bandyopadhyay SK: Complete nucleotide sequence analysis of a vaccine strain and a field isolate of foot-and-mouth disease virus serotype Asia1 with an insertion in VP1 genomic region. Acta Virol 2004, 48: 159-166.PubMed
14.
go back to reference Sutmoller P, Casas OR: Unapparent foot and mouth disease infection (sub-clinical infections and carriers): Implications for control. Rev Sci Tech 2002, 21: 519-529.PubMed Sutmoller P, Casas OR: Unapparent foot and mouth disease infection (sub-clinical infections and carriers): Implications for control. Rev Sci Tech 2002, 21: 519-529.PubMed
15.
go back to reference Fry EE, Lea SM, Jackson T, Newman JW, Ellard FM, Blakemore WE, Abu-Ghazaleh R, Samuel A, King AM, Stuart DI: The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J 1999, 18: 543-554. 10.1093/emboj/18.3.543PubMedPubMedCentralCrossRef Fry EE, Lea SM, Jackson T, Newman JW, Ellard FM, Blakemore WE, Abu-Ghazaleh R, Samuel A, King AM, Stuart DI: The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J 1999, 18: 543-554. 10.1093/emboj/18.3.543PubMedPubMedCentralCrossRef
16.
go back to reference Borrego B, Novella IS, Giralt E, Andreu D, Domingo E: Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. J Virol 1993, 67: 6071-6079.PubMedPubMedCentral Borrego B, Novella IS, Giralt E, Andreu D, Domingo E: Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. J Virol 1993, 67: 6071-6079.PubMedPubMedCentral
17.
18.
go back to reference Nylander JA, Ronquist F, Huelsenbeck JP, Nieves-Aldrey JL: Bayesian phylogenetic analysis of combined data. Syst Biol 2004, 53: 47-67. 10.1080/10635150490264699PubMedCrossRef Nylander JA, Ronquist F, Huelsenbeck JP, Nieves-Aldrey JL: Bayesian phylogenetic analysis of combined data. Syst Biol 2004, 53: 47-67. 10.1080/10635150490264699PubMedCrossRef
19.
go back to reference Huelsenbeck JP, Ronquist F: MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 2001, 17: 754-755. 10.1093/bioinformatics/17.8.754PubMedCrossRef Huelsenbeck JP, Ronquist F: MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 2001, 17: 754-755. 10.1093/bioinformatics/17.8.754PubMedCrossRef
20.
go back to reference Cottam EM, Haydon DT, Paton DJ, Gloster J, Wilesmith JW, Ferris NP, Hutchings GH, King DP: Molecular epidemiology of the foot-and-mouth disease virus outbreak in the United Kingdom in 2001. J Virol 2006, 80: 11274-11282. 10.1128/JVI.01236-06PubMedPubMedCentralCrossRef Cottam EM, Haydon DT, Paton DJ, Gloster J, Wilesmith JW, Ferris NP, Hutchings GH, King DP: Molecular epidemiology of the foot-and-mouth disease virus outbreak in the United Kingdom in 2001. J Virol 2006, 80: 11274-11282. 10.1128/JVI.01236-06PubMedPubMedCentralCrossRef
21.
go back to reference van Rensburg H, Haydon D, Joubert F, Bastos A, Heath L, Nel L: Genetic heterogeneity in the foot-and-mouth disease virus leader and 3C proteinases. Gene 2002, 289: 19-29. 10.1016/S0378-1119(02)00471-7PubMedCrossRef van Rensburg H, Haydon D, Joubert F, Bastos A, Heath L, Nel L: Genetic heterogeneity in the foot-and-mouth disease virus leader and 3C proteinases. Gene 2002, 289: 19-29. 10.1016/S0378-1119(02)00471-7PubMedCrossRef
Metadata
Title
Genetic characterisation of the recent foot-and-mouth disease virus subtype A/IRN/2005
Authors
Joern Klein
Manzoor Hussain
Munir Ahmad
Preben Normann
Muhammad Afzal
Soren Alexandersen
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2007
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-4-122

Other articles of this Issue 1/2007

Virology Journal 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine